India’s pharmaceutical sector opened FY27 with mixed but largely positive results across exports, domestic sales, and global markets. Pharma exports rose 6.8 percent year over year to USD 8.1 billion in Q1 FY27. Several drugmakers also...
Manufacturing quality at Aurobindo Pharma's Eugia business faces renewed scrutiny after the US Food and Drug Administration issued a warning letter to its Unit-I facility in Telangana
Drug quality has become a bigger regulatory priority in India as authorities intensify inspections to strengthen manufacturing standards
Osteoarthritis treatment could see a new stem cell-based approach after Bengaluru-based Stempeutics Research secured a US patent.
Drug Resistance is becoming harder to manage as bacteria stop responding to commonly used antibiotics. Wockhardt is now targeting this challenge through a new scientific learning platform.
Drug approvals, MedTech innovation, and pharma legal battles are driving major healthcare developments across global and Indian markets
Indian pharma is gaining a stronger foothold in Nigeria as bilateral economic ties expand and companies deepen their presence across Africa
Gujarat is drawing fresh pharma investment worth INR 2,500-3,000 crore. The money is going into new drug manufacturing facilities across the state. The investment follows approvals for 59 new allopathic medicine plants during FY2025-26.
Gland Pharma reported a strong Q1 profit. The company posted revenue of INR 1,800.27 crore in Q1 FY27. Its net profit rose 47.1% year over year to INR 316.95 crore.
India’s TB screening drive has uncovered a major number of cases, highlighting the scale of hidden tuberculosis. More than 2.2 crore people were screened during the 100-day campaign, with over 7 lakh TB cases detected. Union Health Minister...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")